The Journal of Infectious Diseases · 1994 · 50 citations · 25 references
Veterinary MedicineImmunologyInfectious DiseasesHost-pathogen InteractionsImmunology Of Infectious DiseasesVaccinologyLyme DiseaseTick BiologyTick-borne DiseasesBorrelia Burgdorferi InfectionLyme Disease EpidemiologyLyme Disease VaccinesSerological AntigensTick-borne Pathogens
Five distinct seroprotective groups among North American and European isolates of Borrelia burgdorferi sensu stricto, Borrelia garinii, and Borrelia afzelii have been identified using the in vitro borreliacidal assay. The predominant North American seroprotective group comprised isolate 297 and B. burgdorferi isolates from California, Illinois, Wisconsin, New York, and Texas. A second group was represented by isolate C-1-11. The majority of European isolates belonged to a seroprotective group composed of B. garinii. Another European group contained isolates classified genetically as genospecies group VS461 (B. afzelii). A fifth group, represented by isolate LV5, could kill both North American and European isolates of B. burgdorferi sensu lato. These results suggest that combinations of immunogenic protective proteins of spirochetes will be necessary to provide a comprehensive vaccine.
25
Isolation and cultivation of Lyme disease spirochetes.
Alan G. Barbour · PubMed · 1985 · 1.6K citations · Full text
Bettina Wilske, V. Preac‐Mursic, Ulf B. Göbel et al. · Journal of Clinical Microbiology · 1993 · 355 citations · Full text
U E Schaible, Michael D. Kramer, Klaus Eichmann et al. · Proceedings of the National Academy of Sciences · 1990 · 278 citations · Full text
Richard T. Marconi, Claude F. Garon · Journal of Clinical Microbiology · 1992 · 206 citations · Full text
Veterinary Medicine, Infectious Diseases, Molecular Biology +16
Markus M. Simon, Ulrich E. Schaible, Michael D. Kramer et al. · The Journal of Infectious Diseases · 1991 · 178 citations